4‘-Arylpyrrolomorphinans: Effect of a Pyrrolo-N-benzyl Substituent in Enhancing δ-Opioid Antagonist Activity
摘要:
A new method for the preparation of N-benzylpyrrolomorphinans has been developed. Thus Michael reaction of the benzylimines of oxycodones and oxymorphones with nitrostyrenes gave a series of 4'-aryl-N-benzylpyrrolomorphinans. These were selective delta antagonists of much higher in vitro potency (with 5a having K-e delta = <1 nM) than their binding affinities predicted. In mice in vivo assays 5a showed good delta antagonist activity in the antiwrithing analgesic assay and also inhibited delta agonist-induced convulsant activity.
[EN] PROCESS FOR THE PREPARATION OF MORPHINANE COMPOUNDS<br/>[FR] PROCÉDÉ DE PRÉPARATION DE COMPOSÉS DE MORPHINANE
申请人:SANECA PHARMACEUTICALS A S
公开号:WO2019009820A1
公开(公告)日:2019-01-10
The invention describes the process of catalytic O-demethylation of 3-methoxy-morphinane compounds using boron tribromide. Addition of catalysts reduces the reaction time, improves reacting the substrate to give the product in very good purity and yield. The said approach can be used, for example, for the preparation of oxymorphone, naltrexone, naloxone and nalbuphine from their respective O-methyl derivatives.
PROCESS FOR THE PREPARATION OF MORPHINANE COMPOUNDS
申请人:Saneca Pharmaceuticals a.s.
公开号:EP3649131A1
公开(公告)日:2020-05-13
4‘-Arylpyrrolomorphinans: Effect of a Pyrrolo-<i>N</i>-benzyl Substituent in Enhancing δ-Opioid Antagonist Activity
作者:Sanjay K. Srivastava、Stephen M. Husbands、Mario D. Aceto、Carl N. Miller、John R. Traynor、John W. Lewis
DOI:10.1021/jm010841w
日期:2002.1.1
A new method for the preparation of N-benzylpyrrolomorphinans has been developed. Thus Michael reaction of the benzylimines of oxycodones and oxymorphones with nitrostyrenes gave a series of 4'-aryl-N-benzylpyrrolomorphinans. These were selective delta antagonists of much higher in vitro potency (with 5a having K-e delta = <1 nM) than their binding affinities predicted. In mice in vivo assays 5a showed good delta antagonist activity in the antiwrithing analgesic assay and also inhibited delta agonist-induced convulsant activity.